Orchestrated events, including extensive changes in epigenetic marks, allow a somatic nucleus to 1 7 become totipotent after transfer into an oocyte, a process termed nuclear reprogramming.
Cloning by somatic cell nuclear transfer (SCNT) is an inefficient technique largely because of Finally, treatment of SCNT-derived embryos with UNC0638 did not impact on both 1 3 2 cleavage (p = 0.65) and blastocyst (p = 0.13) rates (Table 2) . In summary, our findings indicate that the treatment with UNC0638 was able to reduce 1 3 6 the levels of H3K9me2 regardless of treating either donor cells or the early embryo derived from 1 3 7 7 SCNT. Importantly, the lower levels of H3K9me2 were maintained throughout the 1 3 8 preimplantation development, but this failed to enhance developmental rates. Additionally, the 1 3 9 levels of H3K9me3, 5mC and 5hmC in SCNT-derived embryos were impacted by the UNC0638 used UNC0638, a small molecule that specifically inhibits the catalytic activity of histone 1 4 6 methyltransferases EHMT1/2 in a non-toxic manner as previously shown in mice and sheeps 1 4 7 27,28 . Likewise, our treatment proved effective, resulting in lower levels of H3K9me2 in somatic 1 4 8 cells exposed to UNC0638. This reduction was observed throughout embryogenesis of SCNT 1 4 9 embryos, regardless of the moment of the treatment (i.e. in donor cells or in early embryos). We 1 5 0 then hypothesized that distinct time of expression between H3K9me2 writers and erasers might 1 5 1 explain the lower levels of H3K9me2 since the expression of EHMT1 and EHMT2 in bovine is 1 5 2 higher in oocytes than in early embryos 29 while the expression of lysine demethylases is 1 5 3 increased later in development 30 . Herein, we found no effect of the UNC0678 treatment when 1 5 4 main regulatory genes were analyzed (Figure 7) . This result is consistent with a previous report 1 5 5
with somatic cells in which the UNC0638 treatment did not affect neither the protein levels of 1 5 6 EHMT1 or EHMT2 nor the mRNA levels of EHMT2, indicating that changes in H3K9me2 were 1 5 7 a consequence of decreased enzymatic activity 28 . As expected, different epigenetic marks were also found to be changed herein by Due to the fact that 5mC is required for 5hmC formation 36,37 , we speculate that the 1 7 3 increase in 5hmC was likely a consequence of increased 5mC availability. Actually, we expected Moreover, a previous work showed that the treatment with an EHMT2 inhibitor not only methylase activity 24, 38 . However, the process involved in this offset mechanism remains elusive. Finally, its noteworthy that the unaltered transcript levels of UNC0638-treated embryos 1 8 9
suggest a very specific effect of the treatment on EHMT1/2 inhibition. This is consistent with the period to test H3K9me3 reduction-based approaches. Taken together, these data suggest that Using a specific probe to inhibit the catalytic activity of EHMT1/2, we were able to reprogramming in cattle. Nonetheless, although lower levels of H3K9me2 and H3K9me3 were 2 1 0 achieved at the blastocyst stage, EHMT1/2 inhibition did not increase developmental rates. Therefore, the aberrant epigenetic remodeling present in SCNT-derived embryos may not be amended by inhibiting the catalytic activity of these epigenetic writers. All chemicals and reagents used were purchased from Sigma-Aldrich Chemical Company (St. principles of animal research. We adopted the International Guiding Principles for Biomedical 2 2 0
Research Involving Animals (Society for the Study of Reproduction) as well. mm Petri dishes and cultured for 6 days in an incubator to establish the primary culture. After 2 2 9 1 1 achievement of 70% of confluence (approximately 4x10 5 cells), cells were detached from the 2 3 0 plate using Tryple Express (GIBCO BRL); resuspended in culture medium supplemented with 2 3 1 10% of dimethyl sulfoxide (DMSO), and 50 μ g/mL gentamicin sulfate; placed in cryotubes; and 2 3 2 stored in liquid N 2 until use. Cell treatment with UNC0638. For nuclear donor treatment, primary fetal fibroblasts were 2 3 5 thawed and cultured as described above. After 24 h, culture medium was replaced with fresh 2 3 6 medium containing 250nM of UNC0638, best concentration described previously 28 . Forty-eight Immunostaining of somatic cells. For H3K9me2 and H3K9me3 analysis, we procedure as 2 4 5 described previously 50,51 with few modifications. Cells were plated on coverslips and treated as 2 4 6 described above. Then, cells were fixed with 4% paraformaldehyde for 15 min and buffer, a mouse antibody anti-H3K9me2 -Abcam (ab1220, 1:300) and a rabbit antibody anti-
H3K9me3 -Abcam (ab8898, 1:500), overnight at 4 °C. Cells incubated without primary 2 5 1 antibodies were used as negative controls for all assays. In the next day, after washing 3x for 10 maturation, the fused SCNT couplets were activated with 5 µM ionomycin in TCM199-HEPES 3 2 0
(supplemented with 1 mg/mL fatty acid-free BSA) for 5 minutes and moved into TCM199- in vitro culture was made using activated metaphase II-arrested oocytes, using the same collected either for immunostaining procedure or for gene expression analysis. activation), and blastocyst at day 7 after activation were collected and washed in PBS+PVA. Then, embryos were fixed with 4% paraformaldehyde for 15 min and permeabilized with D-PBS 3 3 8 + 1% Triton X-100 for 30min. Exclusively for 5mC and 5hmC staining, following 3 3 9
permeabilization step, we treated embryos with 4N HCl for 15 min. Next, we proceed with (ab10805, 1:500), and a rabbit antibody anti-5-hydroxymethylcytosine (5-hmC) antibody - cat. # P36935). Z-stack images were captured using a confocal microscope (TCS-SP5 AOBS;
3 5 1
Leica, Soims, Germany) using laser excitation and emission filters specific for Alexa 488 and to the manufacturer's instruction. Quality and quantification of RNA were performed using 3 6 5
NanoDrop 2000 spectrophotometer (Thermo Fisher Scientific; Absorbance 260/280nm ratio).
6 6
Next, RNA was treated with Deoxyribonuclease I, Amplification Grade (DNaseI, Invitrogen; Mix (Applied Biosystems), 1 µM/mL of forward and reverse bovine-specific primers, 6.95ng of 3 7 7
cDNA and nuclease-free water. The primers were designed using the software Primer-BLAST 3 7 8
(NCBI) based upon sequences available in GenBank (Supplemental Table 1 ). The primers were 3 7 9
also sequenced to test their specificity. DNTM1, DNMT3A, DNMT3B and the reference genes PPIA and RPL15 were used as described previously 54, 55 . Amplification were performed with 3 8 1 initial denaturation at 95°C for 2 minutes, following by 45 cycles at 95°C for 15 seconds and geometric mean of PPIA and RPL15 reference genes. Software, San Diego, California, USA). Data were tested for normality of residuals and Data Availability. The datasets generated during and/or analyzed during the current study are 3 9 8
available from the corresponding author on reasonable request. The authors would like to thank the staff and students at the LMMD, Jessica Brunhara Cruz, H3K9me2 and H3K9me3 fluorescence intensity in nuclei of fibroblasts treated or not with with antibody anti-H3K9me2 (green), anti-H3K9me3 (red), anti-5mC (cyan), and anti-5hmC 5 7 7
(magenta), respectively. Merge images from H3K9me2+H3K9me3 and 5mC+5hmC are 5 7 8 displayed in columns 3 and 6, respectively. All images were taken at the same magnification and with antibody anti-H3K9me2 (green), anti-H3K9me3 (red), anti-5mC (cyan), and anti-5hmC 5 9 2 (magenta) are displayed in columns 3 and 6, respectively. All images were taken at the same 5 9 3 magnification and at the same laser power, thereby enabling direct comparison of signal (NT-Control N=10; NT-UNC N=8) and 5mC + 5hmC (NT-Control N=8; NT-UNC0638 N=9).
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Data as presented as mean ± S.E.M, and bars with different letters are significantly different respectively. All images were taken at the same magnification and at the same laser power, 
